USPTO serial 79286375
REALEASE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 9, 2021
- Examiner
- RIBAUDO, MICHELLE RACHEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with REALEASE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products, namely, antibody-dye conjugates for industrial and scientific purposes, all being non-medical purposes; reagents for use in separation processes for biological materials for non-medical purposes; reagents for cell separation for non-medical purposes; cell labeling reagents for non-medical purposes; cell culturing media, substances and ingredients for the preparation of cell culturing media, all for scientific purposes and for the use in medical laboratories; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material, for non-medical purposes; reagents with magnetic beads for cell separation for non-medical purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments, for non-medical purposes; reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; culture media, cell culture media, freezing media, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry, for non-medical purposes | ACTIVE | — |
| 005 | Chemical, biological and biochemical products, namely, antibody-dye conjugates for medical therapeutic and diagnostic purposes; pharmaceutical, medical and veterinary products as well as products for the pharmaceutical, medical and veterinary science, namely, antibody-dye conjugates, and pharmaceutical and other preparations, namely, antibody-dye conjugates for medical or veterinary purposes; reagents for medical or veterinary purposes, cell culturing media for medical or veterinary purposes, materials and ingredients for the preparation of cell culturing media for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, and antibody reagents, all for medical or veterinary purposes; buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments all for medical or veterinary purposes; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media, cell culture media, diagnostic reagents and preparations for medical and veterinary purposes; freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, especially pharmaceutical products for the cellular therapy | ACTIVE | — |
| 009 | Scientific, optical and measuring apparatus and instruments, namely, imaging devices or microscopes for analysis of cells or tissue, especially for and in connection with the separation, analysis, processing and cultivation of biological material; apparatus for recording, transmission or reproduction of images, especially for or in connection with the separation, analysis, processing and cultivation of biological material, scientific, electrical and electronic apparatus and instruments for conducting enzymatic reactions; data processing equipment especially for or in connection with the separation, analysis, processing and cultivation of biological material, scientific, electrical and electronic apparatus and instruments for conducting enzymatic reactions; downloadable computer software for imaging devices or microscopes for analysis of cells or tissue, especially for or in connection with the separation, analysis, processing and cultivation of biological material, scientific, electrical and electronic apparatus and instruments for conducting enzymatic reactions; laboratory equipment, namely, cytometer for measuring physical and chemical properties of cells and other particles in suspensions | ACTIVE | — |
| 010 | Apparatus for magnetic cell separation for medical purposes; tubing sets for drainage, transfusion, administering drugs for medical purposes; columns for analysis for medical purposes; sacks, bags, sheets, tubes and connectors for medical, scientific or biotechnological purposes, in particular for cryopreservation; apparatus and instruments, namely, imaging devices or microscopes for analysis of cells or tissue for medical and biotechnological medical purposes; veterinary apparatus and instruments, namely, imaging devices or microscopes for analysis of cells or tissue; surgical apparatus and instruments; dental apparatus and instruments, namely, imaging devices or microscopes for analysis of cells or tissue; medical apparatus and instruments, namely, imaging devices or microscopes for analysis of cells or tissue | ACTIVE | — |
| 042 | Scientific and technological services in the nature of medical imaging of cells or tissue and research and design services relating hereto; development of computer hardware; medical research; industrial analysis of cells and tissue; industrial research in the field of cells and tissue | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named REALEASE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 9, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 11, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 9, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 24, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 24, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 4, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 21, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 21, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 21, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 21, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 21, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 25, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 24, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 14, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 14, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 14, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 14, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 14, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 8, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 8, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 8, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 7, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 29, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 29, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 28, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |